Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.
Ersek A, Xu K, Antonopoulos A, Butters TD, Santo AE, Vattakuzhi Y, Williams LM, Goudevenou K, Danks L, Freidin A, Spanoudakis E, Parry S, Papaioannou M, Hatjiharissi E, Chaidos A, Alonzi DS, Twigg G, Hu M, Dwek RA, Haslam SM, Roberts I, Dell A, Rahemtulla A, Horwood NJ, Karadimitris A. Ersek A, et al. Among authors: karadimitris a. J Clin Invest. 2015 Jun;125(6):2279-92. doi: 10.1172/JCI59987. Epub 2015 Apr 27. J Clin Invest. 2015. PMID: 25915583 Free PMC article.
Natural killer T cells and haemopoiesis.
Karadimitris A, Patterson S, Spanoudakis E. Karadimitris A, et al. Br J Haematol. 2006 Aug;134(3):263-72. doi: 10.1111/j.1365-2141.2006.06187.x. Br J Haematol. 2006. PMID: 16848769 Free article. Review.
Regulation of multiple myeloma survival and progression by CD1d.
Spanoudakis E, Hu M, Naresh K, Terpos E, Melo V, Reid A, Kotsianidis I, Abdalla S, Rahemtulla A, Karadimitris A. Spanoudakis E, et al. Among authors: karadimitris a. Blood. 2009 Mar 12;113(11):2498-507. doi: 10.1182/blood-2008-06-161281. Epub 2008 Dec 3. Blood. 2009. PMID: 19056691 Free article.
Activated invariant NKT cells regulate osteoclast development and function.
Hu M, Bassett JH, Danks L, Howell PG, Xu K, Spanoudakis E, Kotsianidis I, Boyde A, Williams GR, Horwood N, Roberts IA, Karadimitris A. Hu M, et al. Among authors: karadimitris a. J Immunol. 2011 Mar 1;186(5):2910-7. doi: 10.4049/jimmunol.1002353. Epub 2011 Jan 28. J Immunol. 2011. PMID: 21278350
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.
Chaidos A, Barnes CP, Cowan G, May PC, Melo V, Hatjiharissi E, Papaioannou M, Harrington H, Doolittle H, Terpos E, Dimopoulos M, Abdalla S, Yarranton H, Naresh K, Foroni L, Reid A, Rahemtulla A, Stumpf M, Roberts I, Karadimitris A. Chaidos A, et al. Among authors: karadimitris a. Blood. 2013 Jan 10;121(2):318-28. doi: 10.1182/blood-2012-06-436220. Epub 2012 Nov 20. Blood. 2013. PMID: 23169779 Free article.
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.
Auner HW, Moody AM, Ward TH, Kraus M, Milan E, May P, Chaidos A, Driessen C, Cenci S, Dazzi F, Rahemtulla A, Apperley JF, Karadimitris A, Dillon N. Auner HW, et al. Among authors: karadimitris a. PLoS One. 2013 Sep 17;8(9):e74415. doi: 10.1371/journal.pone.0074415. eCollection 2013. PLoS One. 2013. PMID: 24069311 Free PMC article.
82 results